drugset / Trial / NCT01333852
Metformin Plus Paclitaxel for Metastatic or Recurrent Head and Neck Cancer
Phase 2
Terminated
45 enrolled
Lucas Vieira dos Santos
Fundação de Amparo à Pesquisa do Estado de São Paulo · collabUniversity of Campinas, Brazil · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Metformin plus paclitaxel for recurrent or metastatic head and neck cancer: a randomized phase II trial
Timeline
- Start
- 2011-02
- Primary completion
- 2014-01
- Completion
- 2014-04
Outcome
Outcome not reported
Stopped (Enrollment): “Low accrual”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | 2500 mg | — |
| Background | Paclitaxel | Small molecule | 175 mg/m2 | — |